Eduardo Rene Salas - Dec 30, 2024 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Eduardo Rene Salas, by Michael A. Goldstein as attorney-in-fact
Stock symbol
ADMA
Transactions as of
Dec 30, 2024
Transactions value $
$0
Form type
4
Date filed
1/2/2025, 04:15 PM
Previous filing
Jun 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMA Stock Option (right to buy) Award $0 +20K $0.00 20K Dec 30, 2024 Common Stock 20K $17.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted to the reporting person on 12/30/2024 upon joining the ADMA Biologics, Inc. Board of Directors and will vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.